FAQ Directory: HEDIS

Filter Results
  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.

9.15.2021 Follow-Up After Emergency Department Visit for Substance Use (FUA) It appears that the medication tables for the Alcohol Use Disorder Treatment Medications List and the Opioid Use Disorder Treatment Medications List needed to identify pharmacotherapy dispensing events in the numerator are not included in the FUA measure. Where can they be found?

The medication tables for the Alcohol Use Disorder Treatment Medications List and the Opioid Use Disorder Treatment Medications List were inadvertently omitted from the measure specifications. The full medication lists are included in the MY 2022 Medication List Directory (MLD). The medication tables can also be found in the following measures: Follow-Up After High-Intensity Care for Substance Use Disorder, Identification of Alcohol and Other Drug Services, Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment.  

HEDIS MY 2022

9.15.2021 Acute Hospital Utilization, Emergency Department Utilization and Hospitalization for Potentially Preventable Complications May covariance values be rounded before using them in the variance calculation?

No. Do not round covariance values for use in variance calculations. Member-level PPD and PUCD should be unrounded in covariance and variance calculations, although truncation to 10 decimal points is applied, per the previous step. NCQA intends to evaluate truncation and rounding logic throughout intermediate calculations to ensure consistency and reduce potential bias in a future publication release.

HEDIS MY 2022

9.15.2021 Acute Hospital Utilization, Emergency Department Utilization and Hospitalization for Potentially Preventable Complications When should rounding occur for variance calculations?

The variance should not be rounded until the final step in the calculation. The final variance calculation for reporting should be rounded to four decimal places using the .5 rule. For example, the PPD and PUCD values are truncated to 10 decimal places, multiplied together at the member level and summed across members for the total. Round the total sum to four decimal places.

HEDIS MY 2022

9.15.2021 Guidelines for Calculations and Sampling: Hybrid Method How should the eligible population be reported for hybrid measures if there are optional or required exclusions?

The eligible population for hybrid measures should be reported before the optional exclusions and after the required exclusions for all three hybrid method approaches (refer to Appendix 4 in HEDIS Volume 2). For example, if the eligible population is 100 members and 10 members met optional exclusion criteria, then the reported eligible population value must still be 100.

HEDIS MY 2021

9.15.2021 PCS Questions Do answers from the Policy Clarification Support system have an expiration date?

We recommend that organizations not use PCS responses that are over 3 years old. If a question relates directly to a measure specification or a general guideline that was revised from a previous measurement year, we recommend resubmitting the question.

HEDIS MY 2022

9.15.2021 Well-Child Visits in the First 30 Months of Life (W30) Does a well child visit with an OB/GYN meet criteria for the W30 measure?

Yes, if the OB/GYN is considered to be a PCP by the health plan (i.e., offers primary care medical services). Refer to Appendix 3 of HEDIS Measurement Year 2022 for the definition of “PCP.”

HEDIS MY 2022

9.15.2021 Acute Hospital Utilization, Emergency Department Utilization and Hospitalization for Potentially Preventable Complications May covariance values be rounded before using them in the variance calculation?

No. Do not round covariance values for use in variance calculations. Member-level PPD and PUCD should be unrounded in covariance and variance calculations, although truncation to 10 decimal points is applied, per the previous step. NCQA intends to evaluate truncation and rounding logic throughout intermediate calculations to ensure consistency and reduce potential bias in a future publication release.

HEDIS MY 2021

7.15.2021 Colorectal Cancer Screening (COL) On May 18, 2021 the U.S. Preventive Services Task Force (USPSTF) updated the colorectal cancer screening recommendations to screen for colorectal cancer in adults aged 45 to 49 years. Will NCQA update the COL measure to coincide with the USPSTF recommendations that lower the screening age to 45? If yes, what HEDIS year can we expect this change to be reflected in the measure specs?

NCQA is aware of updates to the US Preventive Services Task Force (USPSTF) guidelines for colorectal cancer screening. Given these updates, NCQA will evaluate potential changes to the HEDIS Colorectal Cancer Screening (COL) measure through input from our clinical and technical measurement advisory panels, the Committee on Performance Measurement and public comment. Any potential changes to the measure resulting from this evaluation would be included in the HEDIS MY 2022 Technical Update at the earliest.

HEDIS MY 2021

6.15.2021 General Guideline 31 Is data from a certified eCQM vendor considered standard supplemental data?

No. NCQA released a policy change in July 2020 stating that certified QRDA I files are not considered standard supplemental data for HEDIS® reporting in 2022 for HEDIS MY 2021. Because of the dual HEDIS publication, HEDIS MY 2021 Volume 2 did not account for this policy change, but it will be reflected in HEDIS MY 2022 Volume 2. However, this FAQ is a reminder the policy changed in July 2020 and therefore must be followed. Organizations should work with their auditor to have this data validated as nonstandard supplemental data.

 

HEDIS MY 2021

4.15.2021 Antidepressant Medication Management (AMM) For Effective Continuation Phase Treatment, how many days are counted in the 232-day interval if a prescription of a 90-days supply is dispensed on the 151st day?

Count 82 days in the 232-day interval for a prescription of a 90-days supply dispensed on the 151st day.

**This FAQ applies only to HEDIS Volume 2 MY 2021.

HEDIS MY 2021

4.15.2021 Persistence of Beta-Blocker Treatment After a Heart Attack (PBH) How many days are counted in the 180-day interval if a prescription of 90 days supply is dispensed on the 100th day?

Count 81 days in the 180-day interval for a prescription of a 90-days supply dispensed on the 100th day.

**This FAQ applies only to HEDIS Volume 2 MY 2021.
 

HEDIS MY 2021

1.15.2021 Transitions of Care (TRC) Volume 2 states that for MY 2021 reporting, the organization may reduce the sample size using the prior year’s audited, product line-specific rate. Which rate should organizations use for sample size reduction?

Organizations may reduce the sample size for the TRC measure based only on the prior year’s audited, product line-specific rate for the lowest rate among all reported TRC indicators.

HEDIS MY 2021